Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: Preliminary results of a phase II trial

Colomer, R Llombart, A Lluch, A Ojeda, B Barnadas, A Caranana, V Fernandez, Y De Paz, L Guillem, V Alonso, S

R. Colomer et al., Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: Preliminary results of a phase II trial, SEMIN ONCOL, 27(1), 2000, pp. 20-24

23

Oncology,"Onconogenesis & Cancer Research

SEMINARS IN ONCOLOGY

00937754 → ACNP

27

1

2000

2

20 - 24

ISI

0093-7754(200002)27:1<20:PAETWI>2.0.ZU;2-2